Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 12 | 2026 | 60 | 3.060 |
Why?
|
| Liver Neoplasms | 8 | 2019 | 167 | 1.980 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2019 | 133 | 1.570 |
Why?
|
| Tissue and Organ Procurement | 4 | 2020 | 10 | 1.330 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 348 | 1.230 |
Why?
|
| Hepatectomy | 5 | 2019 | 26 | 1.220 |
Why?
|
| Tissue Donors | 4 | 2026 | 29 | 1.090 |
Why?
|
| Organ Preservation | 3 | 2025 | 4 | 1.030 |
Why?
|
| Hemorrhage | 3 | 2012 | 266 | 0.890 |
Why?
|
| Liver | 4 | 2026 | 493 | 0.880 |
Why?
|
| Liver Diseases | 2 | 2012 | 52 | 0.710 |
Why?
|
| Waiting Lists | 3 | 2020 | 10 | 0.690 |
Why?
|
| End Stage Liver Disease | 2 | 2020 | 9 | 0.670 |
Why?
|
| Biliary Tract | 1 | 2019 | 1 | 0.610 |
Why?
|
| Cholangiography | 1 | 2019 | 7 | 0.610 |
Why?
|
| Organ Preservation Solutions | 1 | 2019 | 1 | 0.590 |
Why?
|
| Hepatic Artery | 3 | 2016 | 4 | 0.560 |
Why?
|
| Retrospective Studies | 13 | 2025 | 2651 | 0.550 |
Why?
|
| Policy Making | 1 | 2017 | 13 | 0.520 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 79 | 0.500 |
Why?
|
| Aged | 17 | 2025 | 5627 | 0.440 |
Why?
|
| Perfusion | 2 | 2025 | 43 | 0.430 |
Why?
|
| Organ Transplantation | 2 | 2025 | 13 | 0.430 |
Why?
|
| Middle Aged | 18 | 2025 | 7458 | 0.430 |
Why?
|
| Patient Selection | 4 | 2020 | 151 | 0.390 |
Why?
|
| Hemobilia | 2 | 2012 | 2 | 0.390 |
Why?
|
| Humans | 31 | 2026 | 29078 | 0.380 |
Why?
|
| Male | 21 | 2026 | 14049 | 0.370 |
Why?
|
| Polyarteritis Nodosa | 1 | 2012 | 1 | 0.370 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 17 | 0.370 |
Why?
|
| Treatment Outcome | 8 | 2025 | 2430 | 0.360 |
Why?
|
| Adult | 12 | 2026 | 8080 | 0.360 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 142 | 0.340 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 194 | 0.340 |
Why?
|
| Female | 21 | 2026 | 15740 | 0.340 |
Why?
|
| Time Factors | 7 | 2025 | 1619 | 0.320 |
Why?
|
| Graft Rejection | 5 | 2025 | 34 | 0.310 |
Why?
|
| Duodenum | 2 | 2007 | 18 | 0.310 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2016 | 20 | 0.260 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 1033 | 0.260 |
Why?
|
| Donor Selection | 2 | 2017 | 3 | 0.260 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2007 | 6 | 0.260 |
Why?
|
| Lymphoma, B-Cell | 1 | 2006 | 19 | 0.250 |
Why?
|
| Tissue Survival | 1 | 2026 | 8 | 0.250 |
Why?
|
| Graft Survival | 3 | 2017 | 29 | 0.240 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2006 | 28 | 0.240 |
Why?
|
| Stomach | 1 | 2006 | 43 | 0.240 |
Why?
|
| Aneurysm | 1 | 2006 | 25 | 0.240 |
Why?
|
| Pancreatectomy | 1 | 2006 | 58 | 0.240 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2025 | 2 | 0.230 |
Why?
|
| Biliary Tract Diseases | 1 | 2025 | 6 | 0.230 |
Why?
|
| Tacrolimus | 1 | 2025 | 6 | 0.230 |
Why?
|
| Tomography, Optical Coherence | 1 | 2026 | 100 | 0.230 |
Why?
|
| Immunosuppressive Agents | 2 | 2025 | 151 | 0.230 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2019 | 118 | 0.220 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2020 | 45 | 0.220 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 226 | 0.220 |
Why?
|
| Risk Factors | 6 | 2025 | 2138 | 0.210 |
Why?
|
| Precision Medicine | 1 | 2025 | 82 | 0.210 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 480 | 0.210 |
Why?
|
| Postoperative Complications | 3 | 2025 | 639 | 0.200 |
Why?
|
| Aneurysm, False | 2 | 2016 | 19 | 0.190 |
Why?
|
| Young Adult | 4 | 2019 | 2855 | 0.170 |
Why?
|
| Drainage | 2 | 2019 | 45 | 0.170 |
Why?
|
| Survival Rate | 3 | 2017 | 433 | 0.170 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2020 | 6 | 0.170 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2020 | 4 | 0.170 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 686 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 468 | 0.160 |
Why?
|
| Health Resources | 1 | 2020 | 19 | 0.160 |
Why?
|
| Endoscopy | 1 | 2020 | 57 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 556 | 0.160 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 78 | 0.150 |
Why?
|
| Rupture, Spontaneous | 3 | 2008 | 10 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 54 | 0.150 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 48 | 0.150 |
Why?
|
| Raffinose | 1 | 2019 | 1 | 0.150 |
Why?
|
| Allopurinol | 1 | 2019 | 2 | 0.150 |
Why?
|
| United Kingdom | 2 | 2017 | 80 | 0.150 |
Why?
|
| Adenosine | 1 | 2019 | 33 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 87 | 0.140 |
Why?
|
| Glutathione | 1 | 2019 | 76 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 121 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 206 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2025 | 631 | 0.140 |
Why?
|
| Bile Duct Diseases | 1 | 2017 | 1 | 0.130 |
Why?
|
| Cold Ischemia | 1 | 2017 | 1 | 0.130 |
Why?
|
| Allografts | 1 | 2017 | 11 | 0.130 |
Why?
|
| Insulin | 1 | 2019 | 325 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 41 | 0.130 |
Why?
|
| Health Policy | 1 | 2017 | 63 | 0.120 |
Why?
|
| Age Factors | 2 | 2017 | 740 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2017 | 68 | 0.120 |
Why?
|
| United States | 2 | 2025 | 2252 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2017 | 271 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 485 | 0.120 |
Why?
|
| Coronary Artery Bypass | 2 | 2005 | 68 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2017 | 902 | 0.110 |
Why?
|
| Reoperation | 2 | 2013 | 159 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2017 | 1201 | 0.100 |
Why?
|
| Adolescent | 2 | 2019 | 3233 | 0.100 |
Why?
|
| Victoria | 1 | 2013 | 4 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 236 | 0.090 |
Why?
|
| Adenoma, Liver Cell | 1 | 2012 | 1 | 0.090 |
Why?
|
| HELLP Syndrome | 1 | 2012 | 5 | 0.090 |
Why?
|
| Amylases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2012 | 13 | 0.090 |
Why?
|
| Digestive System Diseases | 1 | 2012 | 3 | 0.090 |
Why?
|
| England | 1 | 2012 | 39 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2012 | 14 | 0.090 |
Why?
|
| Pancreatic Fistula | 1 | 2012 | 14 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 2070 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 35 | 0.090 |
Why?
|
| Cysts | 1 | 2012 | 23 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2012 | 42 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 203 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 288 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2012 | 159 | 0.090 |
Why?
|
| Child | 1 | 2017 | 2335 | 0.080 |
Why?
|
| Cholecystolithiasis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 44 | 0.080 |
Why?
|
| Surgery Department, Hospital | 1 | 2009 | 13 | 0.080 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2007 | 5 | 0.070 |
Why?
|
| Propionates | 1 | 2007 | 11 | 0.070 |
Why?
|
| Pregnancy | 1 | 2012 | 1261 | 0.070 |
Why?
|
| Chylous Ascites | 1 | 2007 | 3 | 0.070 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2007 | 1 | 0.070 |
Why?
|
| Pancreas | 1 | 2007 | 63 | 0.060 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 25 | 0.060 |
Why?
|
| Hepatoblastoma | 1 | 2006 | 6 | 0.060 |
Why?
|
| General Surgery | 1 | 2007 | 63 | 0.060 |
Why?
|
| Arteries | 1 | 2006 | 66 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2005 | 24 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 25 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2005 | 27 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2006 | 244 | 0.060 |
Why?
|
| Transplant Recipients | 1 | 2025 | 12 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2005 | 41 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 73 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2025 | 35 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 74 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 134 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2005 | 108 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 482 | 0.050 |
Why?
|
| Phenotype | 1 | 2025 | 688 | 0.050 |
Why?
|
| Stroke | 1 | 2005 | 261 | 0.040 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 2020 | 1 | 0.040 |
Why?
|
| Hepatic Encephalopathy | 1 | 2020 | 5 | 0.040 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2020 | 3 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 13 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 73 | 0.040 |
Why?
|
| Bias | 1 | 2020 | 42 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2020 | 46 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 20 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 40 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 413 | 0.040 |
Why?
|
| Death | 1 | 2017 | 8 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 1286 | 0.030 |
Why?
|
| Bile Ducts | 1 | 2016 | 6 | 0.030 |
Why?
|
| Angiography | 1 | 2016 | 35 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 1015 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 815 | 0.030 |
Why?
|
| Body Fluids | 1 | 2012 | 18 | 0.020 |
Why?
|
| State Medicine | 1 | 2009 | 4 | 0.020 |
Why?
|
| Workload | 1 | 2009 | 44 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 33 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 574 | 0.020 |
Why?
|
| Peritoneum | 1 | 2007 | 8 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 90 | 0.020 |
Why?
|
| Hepatic Veins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 16 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2007 | 101 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 157 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2007 | 124 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2005 | 4 | 0.010 |
Why?
|
| Nursing Records | 1 | 2005 | 1 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2005 | 11 | 0.010 |
Why?
|
| Nursing Evaluation Research | 1 | 2005 | 9 | 0.010 |
Why?
|
| Skin Care | 1 | 2005 | 3 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2005 | 6 | 0.010 |
Why?
|
| Suppuration | 1 | 2005 | 5 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 46 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2005 | 124 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 126 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 924 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 1056 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 433 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 351 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 538 | 0.010 |
Why?
|